Arcturus Therapeutics Holdings Inc. (ARCT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
3:09 pm
Sale
2020-12-3113GArcturus Therapeutics Holdings Inc.
ARCT
Cormorant Asset Management, LP0
0.000%
-1,144,537decrease
(Position Closed)
Filing
History
2021-02-16
12:24 pm
Purchase
2020-12-3113GArcturus Therapeutics Holdings Inc.
ARCT
T. Rowe Price Associates, Inc.1,422,179
5.400%
1,422,179increase
(New Position)
Filing
History
2021-02-12
4:09 pm
Sale
2020-12-3113GArcturus Therapeutics Holdings Inc.
ARCT
HealthCor Management L.P.0
0.000%
-1,584,466decrease
(Position Closed)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-3113GArcturus Therapeutics Holdings Inc.
ARCT
BlackRock Inc.
BLK
1,781,955
6.900%
1,781,955increase
(New Position)
Filing
History
2021-01-08
2:00 pm
Purchase
2020-12-3113GArcturus Therapeutics Holdings Inc.
ARCT
FEDERATED HERMES INC.
FHI
3,452,810
13.350%
3,452,810increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2